Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07212608 · ClinicalTrials.gov registry record · NA
Personalized Post-Stroke Gait Rehabilitation Interventions
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT07212608 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 22 participants.
The verdict
NCT07212608, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The objective of this study is to understand whether certain post-stroke patient subsets, identified from clinical, biomechanical, and neuromuscular characteristics, preferentially respond to different walking rehabilitation interventions that augment paretic limb propulsion (e.g., soft robotic exosuits or electrical stimulation neuroprostheses). The results of this work could improve post-stroke gait recovery outcomes by informing clinical decision-making to better match patients with rehabilitation devices tailored to their specific gait characteristics.
Interventions
- DEVICE Soft robotic exosuit
- DEVICE Propulsion neuroprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-09-13 |
| Est. Completion | 2025-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07212608
The ClinicalTrials.gov registry entry for NCT07212608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Soft robotic exosuit is the first listed.
NCT07212608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07212608 about?
NCT07212608 is a clinical study titled "Personalized Post-Stroke Gait Rehabilitation Interventions". The objective of this study is to understand whether certain post-stroke patient subsets, identified from clinical, biomechanical, and neuromuscular characteristics, preferentially respond to different walking rehabilitation interventions that augment paretic limb propulsion (e.g., soft robotic exos...
What is the current status of trial NCT07212608?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2022-09-13. Estimated completion is 2025-04-24.
What interventions are being tested in trial NCT07212608?
The interventions under investigation include: Soft robotic exosuit (DEVICE), Propulsion neuroprosthesis (DEVICE).
Who is sponsoring clinical trial NCT07212608?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.